rivastigmín

Rivastigmine is a medication used to treat mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease. It belongs to a class of drugs called cholinesterase inhibitors. These drugs work by increasing the levels of a chemical messenger in the brain called acetylcholine, which is important for memory and thinking. By inhibiting the breakdown of acetylcholine, rivastigmine helps to improve communication between nerve cells, potentially slowing the progression of cognitive decline.

Rivastigmine is available in both oral capsule and transdermal patch forms. The oral form is taken twice daily with food, while the patch is applied to the skin once every 24 hours and replaced daily. The dosage is typically started low and gradually increased based on individual tolerance and response. Common side effects can include nausea, vomiting, diarrhea, loss of appetite, and dizziness. More serious side effects are rare but can include slowed heart rate and stomach ulcers.

It is important for individuals taking rivastigmine to be monitored by a healthcare professional. The medication does not cure Alzheimer's or Parkinson's disease but can help manage symptoms for a period of time. It is not intended for use in individuals with mild cognitive impairment who do not have dementia. Patients should inform their doctor about all other medications they are taking to avoid potential interactions.